References
- Estey E, Dohner H. Acute myeloid leukaemia. Lancet. 2006;368(9550):1894–1907. doi: https://doi.org/10.1016/S0140-6736(06)69780-8
- Bohlander SK. ETV6: a versatile player in leukemogenesis. Semin Cancer Biol. 2005;15(3):162–174. Epub 2005/04/14. PubMed PMID: 15826831. doi: https://doi.org/10.1016/j.semcancer.2005.01.008
- Poirel H, Lacronique V, Mauchauffe M, et al. Analysis of TEL proteins in human leukemias. Oncogene. 1998;16(22):2895–2903. Epub 1998/07/22. PubMed PMID: 9671410. doi: https://doi.org/10.1038/sj.onc.1201817
- Baens M, Peeters P, Guo C, et al. Genomic organization of TEL: the human ETS-variant gene 6. Genome Res. 1996;6(5):404–413. Epub 1996/05/01. PubMed PMID: 8743990. doi: https://doi.org/10.1101/gr.6.5.404
- Hart SM, Foroni L. Core binding factor genes and human leukemia. Haematologica. 2002;87(12):1307–1323. Epub 2002/12/24. PubMed PMID: 12495904.
- Kuno Y, Abe A, Emi N, et al. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood. 2001;97(4):1050–1055. Epub 2001/02/13. PubMed PMID: 11159536. doi: https://doi.org/10.1182/blood.V97.4.1050
- Carroll M, Tomasson MH, Barker GF, et al. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci USA. 1996;93(25):14845–14850. Epub 1996/12/10. PubMed PMID: 8962143; PubMed Central PMCID: PMCPmc26224. doi: https://doi.org/10.1073/pnas.93.25.14845
- Knezevich SR, Garnett MJ, Pysher TJ, et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998;58(22):5046–5048. Epub 1998/11/21. PubMed PMID: 9823307.
- Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2(5):367–376. Epub 2002/11/27. PubMed PMID: 12450792. doi: https://doi.org/10.1016/S1535-6108(02)00180-0
- Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18(2):184–187. Epub 1998/02/14. PubMed PMID: 9462753. doi: https://doi.org/10.1038/ng0298-184
- De Braekeleer E, Douet-Guilbert N, Morel F, et al. ETV6 fusion genes in hematological malignancies: a review. Leuk Res. 2012;36(8):945–961. Epub 2012/05/15. PubMed PMID: 22578774. doi: https://doi.org/10.1016/j.leukres.2012.04.010
- Wlodarska I, La Starza R, Baens M, et al. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. Blood. 1998;91(4):1399–1406. Epub 1998/03/07. PubMed PMID: 9454771.
- Eguchi M, Eguchi-Ishimae M, Tojo A, et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood. 1999;93(4):1355–1363. Epub 1999/02/09. PubMed PMID: 9949179.
- Ding L, Ley TJ, Larson DE, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481(7382):506–510. Epub 2012/01/13. PubMed PMID: 22237025; PubMed Central PMCID: PMCPmc3267864. doi:10.1038/nature10738.
- Baens M, Wlodarska I, Corveleyn A, et al. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p). Genomics. 1999;56(1):40–50. Epub 1999/02/26. PubMed PMID: 10036184. doi: https://doi.org/10.1006/geno.1998.5685
- La Starza R, Stella M, Testoni N, et al. Characterization of 12p molecular events outside ETV6 in complex karyotypes of acute myeloid malignancies. Br J Haematol. 1999;107(2):340–346. Epub 1999/12/03. PubMed PMID: 10583222. doi: https://doi.org/10.1046/j.1365-2141.1999.01724.x
- Sato Y, Suto Y, Pietenpol J, et al. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood. 1995;86(4):1525–1533. Epub 1995/08/15. PubMed PMID: 7632960.
- Yamagata T, Maki K, Waga K, et al. TEL/ETV6 induces apoptosis in 32D cells through p53-dependent pathways. Biochem Biophys Res Commun. 2006;347(2):517–526. Epub 2006/07/11. PubMed PMID: 16828711. doi: https://doi.org/10.1016/j.bbrc.2006.06.127
- Abe A, Yamamoto Y, Iba S, et al. ETV6-LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98-HOXA9. Genes Chromosomes Cancer. 2016;55(3):242–250. Epub 2015/11/07. PubMed PMID: 26542893. doi: https://doi.org/10.1002/gcc.22327
- Unnikrishnan A, Guan YF, Huang Y, et al. A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network. Nucleic Acids Res. 2016;44(22):10644–10661. Epub 2016/09/09. PubMed PMID: 27604872; PubMed Central PMCID: PMCPmc5159545. doi: https://doi.org/10.1093/nar/gkw804
- Manola KN, Georgakakos VN, Margaritis D, et al. Disruption of the ETV6 gene as a consequence of a rare translocation (12;12)(p13;q13) in treatment-induced acute myeloid leukemia after breast cancer. Cancer Genet Cytogenet. 2008;180(1):37–42. Epub 2007/12/11. PubMed PMID: 18068531. doi: https://doi.org/10.1016/j.cancergencyto.2007.09.004
- Haferlach C, Bacher U, Schnittger S, et al. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events. Genes Chromosomes Cancer. 2012;51(4):328–337. Epub 2011/12/14. PubMed PMID: 22162288. doi: 10.1002/gcc.21918
- Sahu SN, Nunez S, Bai G, et al. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells. Am J Physiol Cell Physiol. 2007;292(6):C2288–C2296. Epub 2007/03/03. PubMed PMID: 17329398. doi: https://doi.org/10.1152/ajpcell.00503.2006
- Bruserud O, Ryningen A, Olsnes AM, et al. Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells. Haematologica. 2007;92(3):332–341. Epub 2007/03/07. PubMed PMID: 17339182. doi: https://doi.org/10.3324/haematol.10148
- Peled A, Tavor S. Role of CXCR4 in the pathogenesis of acute myeloid leukemia. Theranostics. 2013;3(1):34–39. Epub 2013/02/06. PubMed PMID: 23382784; PubMed Central PMCID: PMCPmc3563079. doi: https://doi.org/10.7150/thno.5150
- Suzuki C, Daigo Y, Ishikawa N, et al. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 2005;65(24):11314–11325. Epub 2005/12/17. PubMed PMID: 16357138. doi: https://doi.org/10.1158/0008-5472.can-05-1507
- Campregher PV, Pereira WO, Lisboa B, et al. Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis. Mol Cancer. 2015;14:197. Epub 2015/11/21. PubMed PMID: 26584717; PubMed Central PMCID: PMCPmc4653877. doi: https://doi.org/10.1186/s12943-015-0471-5
- Hisaoka M, Sheng WQ, Tanaka A, et al. Gene expression of TrkC (NTRK3) in human soft tissue tumours. J Pathol. 2002;197(5):661–667. Epub 2002/09/05. PubMed PMID: 12210087. doi: https://doi.org/10.1002/path.1138
- Grossmann V, Tiacci E, Holmes AB, et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood. 2011;118(23):6153–6163. Epub 2011/10/21. PubMed PMID: 22012066. doi: https://doi.org/10.1182/blood-2011-07-365320
- Badar T, Johnson L, Trifilo K, et al. Detection of novel t(12;17)(p12;p13) in relapsed refractory acute myeloid leukemia by anchored multiplex PCR(AMP)-based next-generation sequencing. Appl Immunohistochem Mol Morphol. 2017. Epub 2017/02/12. PubMed PMID: 28187034. doi: https://doi.org/10.1097/pai.0000000000000477
- Smith KM, Fagan PC, Pomari E, et al. Antitumor activity of entrectinib, a Pan-TRK, ROS1, and ALK inhibitor, in ETV6-NTRK3-positive acute myeloid leukemia. Mol Cancer Ther. 2018;17(2):455–463. Epub 2017/12/15. PubMed PMID: 29237803. doi: https://doi.org/10.1158/1535-7163.mct-17-0419
- Chi HT, Ly BT, Kano Y, et al. ETV6-NTRK3 as a therapeutic target of small molecule inhibitor PKC412. Biochem Biophys Res Commun. 2012;429(1–2):87–92. Epub 2012/11/08. PubMed PMID: 23131561. doi: https://doi.org/10.1016/j.bbrc.2012.10.087